NCT06617936 2025-07-15
Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.
Shandong Public Health Clinical Center
Phase 2 Recruiting
Clinical Trials
16 trialsNCT06618391 2024-10-01
Local Injection and Systemic Therapy in the Treatment of NSCLC.
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT05203276 2023-06-22
Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC
The First People's Hospital of Lianyungang
Phase 2 Unknown
NCT05574998 2022-10-12
FTANLCNDG
Qianfoshan Hospital
Phase 2 Unknown
NCT05529355 2022-09-07
Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer
Anhui Chest Hospital
Phase 2 Unknown
NCT04303130 2020-03-10
Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT03706703 2018-10-17
Rh-Endostatin (Endostar®) Continuous Intravenous Infusion
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 2 Unknown
NCT03614065 2018-08-03
Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT03123445 2017-04-21
Endostar First-line Treatment of Advanced NSCLC
China Medical University, China
Phase 2 Unknown
NCT02375022 2015-03-24
Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations
Zhejiang University
Phase 2 Unknown
NCT00912392 2014-09-03
Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC)
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Phase 2 Completed
NCT01327235 2014-08-01
Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 2 Completed
NCT02005120 2013-12-20
Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC
Zhejiang University
Phase 2 Unknown
NCT01218594 2012-10-17
DP-EN-RT
Sun Yat-sen University
Phase 2 Unknown
NCT01687439 2012-09-19
Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC)
Fudan University
Phase 2 Completed
NCT01158144 2010-07-08
Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)
Zhejiang Cancer Hospital
Phase 2 Unknown